Bx Velocity Rx
Navigation Links
Bx Velocity Rx
| Products | Bx Velocity Rx |
| Company | Cordis Corporation |
| Item | Bx Velocity Rx |
| Features | Closed-cell with FlexSegment design. Smooth Delivery with continuous flexibility and snag-free stent surface and available in different sizes and wide selection of lengths. |
| Description | Rapid Exchange Stent Delivery System |
| Info | Cordis Corporation Customer Service: (800) 327-7714 Web site: http://www.cordis.com/ |
Related medicine products :
1. Bx Velocity Hepacoat
2. Bx Velocity Rx with Hepacoat
3. Velocity Web-Based LIS
4. SphygmoCor Vx Central Blood Pressure/Pulse Wave Velocity System
TAG: Velocity
Breaking Medicine News(10 mins):Health News:Polar Pump: E85 Fuel Now Available in Warroad, Minn., Northernmost Outlet for the Fuel in USA 2Health News:Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research 2Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 2Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 3Health News:Bone Marrow Transplants May Cure Sickle Cell in Adults 4Health News:Genetic Test May Someday Help Spot Breast Cancer 2Health News:Genetic Test May Someday Help Spot Breast Cancer 3Health News:Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball 2Health News:Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball 3
[0] Polar Pump: E85 Fuel Now Available in Warroad, Minn., Northernmost Outlet for the Fuel in USA[0] Rachel Alexandra, Kendall-Jackson Donate $20,000 to V Foundation for Cancer Research[0] Bone Marrow Transplants May Cure Sickle Cell in Adults [0] Genetic Test May Someday Help Spot Breast Cancer[1] Dr. Daniel Von Hoff named honoree of Scottsdale Healthcare Foundation Honor Ball
Other Medicine News:Health News:Nutrition 21 to Report Preliminary First Quarter Fiscal Year 2009 Financial Results on Thursday, November 13, 2008 2Health News:Response Biomedical Closes $5.1 Million Financing 2Health News:Response Biomedical Closes $5.1 Million Financing 3Health News:Response Biomedical Closes $5.1 Million Financing 4Health News:Special Mouth Rinse Spots, Tracks Human Papillomavirus Infection 2Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 2Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 3Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 4Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 5Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 6Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 7Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 8Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 9Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 10Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 11Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 12Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 13Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 14Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 15Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 16Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 17Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 18Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 19Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 20Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 21Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 22Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 23Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 24Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 25Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 26Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 27Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 28Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 29Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 30Health News:Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1): 31
Nutrition 21 to Report Preliminary First Quarter Fiscal Year 2009 Financial Results on Thursday, November 13, 2008Response Biomedical Closes $5.1 Million FinancingSpecial Mouth Rinse Spots, Tracks Human Papillomavirus InfectionSanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):Estrogen and progesterone receptor isoforms expression in the stomach of Mongolian gerbilsPacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
Breaking Medicine Technology:Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Al Novak Elected Chairman of the Board of OrbusNeich Medical 2MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 1MDS Inc Completes Divestiture of MDS Pharma Services Phase II IV Operations 50506 2Align Technology to Announce Second Quarter Fiscal 2009 Results on July 23 2009 50501 1Align Technology to Announce Second Quarter Fiscal 2009 Results on July 23 2009 50501 2Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 1Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |